Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

11results about "Product crystals bed crystallization" patented technology

A production process for producing metallic magnesium and industrial silicon by decomposing serpentine using the hydrochloric acid method.

PendingJP2026089037AElectrolysis componentsMagnesium chlorides
This invention provides a production process for manufacturing metallic magnesium and industrial silicon by decomposing serpentine using the hydrochloric acid method. [Solution] The present invention provides a method for processing serpentine ore as a raw material using a two-stage countercurrent hydrochloric acid leaching process. The wet process steps include storage and filtration of the slurry after ore dressing, two-stage hydrochloric acid leaching under atmospheric pressure, washing and filtration of the silicon slag after leaching, removal of iron and nickel precipitation from the leaching solution, separation, washing and filtration of the obtained iron hydroxide and nickel hydroxide, crystallization and evaporation of the magnesium chloride solution, and production of hydrochloric acid using the gas generated after the thermal decomposition of magnesium chloride. The present invention has developed a serpentine decomposition technology using hydrochloric acid, a metallic magnesium production process using a drying-electrolytic method, and a process for producing industrial silicon by smelting silicon slag in an electric furnace.
Owner:TOLI COUNTY ZHONGDA MAGNESIUM IND CO LTD

A production method for improving the content of anthracene and carboline in crude anthracene product by using crystal nucleus seed

This invention belongs to the technical field of anthracene oil processing and production, and discloses a production method for increasing the anthracene and carbide content in crude anthracene products using crystal nucleus seeds. The method mainly involves cooling the heated raw anthracene oil to 75°C, then adding high-quality crystal nucleus seeds (70% anthracene content, 17% carbide content, and ≤1% mechanical impurities) to a crystallization tank at a mass ratio of 1:75. At this point, the high-quality crystal nucleus seeds promote the formation of new crystal nuclei in the anthracene oil liquid. As the temperature decreases, the newly formed crystal nuclei gradually grow. Simultaneously, the temperature is naturally lowered to below 65°C through stirring, and the cooling system in the crystallization tank is activated to further cool the temperature to 35-40°C. The mixture is then repeatedly fed and dried in a centrifuge to produce high-quality crude anthracene. This invention utilizes unique high-quality crystal nucleus seeds to achieve an anthracene content of over 40% and a carbide content of over 14% in crude anthracene even when the anthracene and carbide content in the raw anthracene oil is low or unstable, resulting in a superior-grade crude anthracene product.
Owner:SHANXI XINHAIXIANG NEW MATERIAL CO LTD

Crystalline forms of picolinamide fungicide compound

The present technology relates to processes useful for making crystalline S)-1, 1-bis(4-fluorophenyl)propan-2-yl (3-acetoxy-4-methoxypicolinoyl)-Lalaninate Compound (I) comprising: distilling a mixture comprising: an aprotic organic solvent, a protic organic solvent, Compound (I) and seed Compound (I), or comprising: distilling a mixture comprising: an aprotic organic solvent and Compound (I), and crystallizing Compound (I) by creating a second mixture comprising: a protic organic solvent, Compound (I) and seed Compound (I). Processes disclosed herein describe more stable, storage compatible preparations of Compound (I). Also disclosed are preparations of Compound (I) which have fewer (trace) impurities.
Owner:CORTEVA AGRISCIENCE LLC

Method for preparing metallic magnesium and industrial silicon by decomposing serpentine with hydrochloric acid

PendingEP4744750A1Electrolysis componentsMagnesium chlorides
A method for preparing metallic magnesium and industrial silicon by decomposing serpentine with hydrochloric acid is provided. Serpentine is used as a raw material, and is processed by a two-stage countercurrent leaching process in a hydrochloric acid system. A hydrometallurgical process is adopted, including beneficiation, wet grinding, slurry storage, filtration, two-stage atmospheric pressure hydrochloric acid leaching, washing and filtration of leached silica slag, iron removal and nickel precipitation from a leachate, separation, washing and filtration of a ferric hydroxide precipitate and a nickel hydroxide precipitate, crystallization and evaporation of a magnesium chloride solution, and hydrochloric acid preparation from a flue gas generated after thermal decomposition of magnesium chloride. The present disclosure develops a process of decomposing serpentine with hydrochloric acid and producing metallic magnesium by a drying-electrolysis method, and a process of producing industrial silicon by smelting silica slag in an electric furnace.
Owner:TOLI COUNTY ZHONGDA MAGNESIUM IND CO LTD

Methods for recovering organic acids or salts or lactones thereof from aqueous solutions using water solvent crystallization and compositions thereof

Compositions and methods are provided for producing crystalline forms of organic acids or salts or lactones thereof from an aqueous solution. More specifically, methods are provided for producing a crystalline form of a salt of mevalonic acid (also referred to as X-MVA) from an aqueous solution, comprising subjecting the aqueous solution comprising said X-MVA to a purification step to produce a purified solution and crystallizing said X-MVA from said purified solution by water solvent crystallization. Methods are also provided for producing mevalonolactone from an aqueous solution comprising X-MVA, comprising subjecting the aqueous solution comprising said X-MVA to cation exchange thereby converting said aqueous solution comprising X-MVA to an aqueous solution comprising mevalonolactone (MVL). Methods are also provided for producing mevalonolactone monohydrate crystals.
Owner:DANISCO US INC

Continuous process for producing crystalline monosaccharides and apparatus for continuous crystallization

ActiveEP3891161B1From normal temperature solutionsSugar crystal separation
The invention relates to a continuous method for obtaining a crystalline monosaccharide, comprising: continuous crystallization of the monosaccharide in a main crystallizer (10), wherein crystallization by evaporation and / or crystallization by cooling is carried out continuously on a crystal suspension in the main crystallizer in order to allow crystals of the monosaccharide to grow in the crystal suspension; separation of crystals of the monosaccharide out of the crystal suspension to obtain crystalline monosaccharide; continuous formation of a mass of crystallization magma for the main crystallizer (10) in a cascade, wherein the cascade comprises at least one first stage (13) and a final stage (15) connected in series and each stage comprises at least one pre-crystallizer (13A, 15A), wherein, in the at least one pre-crystallizer (13A) of the first stage (13), a solution is seeded with monosaccharide by means of monosaccharide seed crystals in order to obtain a pre-crystallization magma, and a mass of crystallization magma for the downstream stage (14, 15) is formed from the pre-crystallization magma by means of crystallization by cooling and / or crystallization by evaporation, and wherein a solution containing monosaccharide and a mass of crystallization magma from the upstream stage is supplied to the at least one pre-crystallizer (15A, 15B, 15C) of the final stage (15) to obtain a pre-crystallization magma, and in the at least one pre-crystallizer (15A, 15B, 15C) of the final stage (15) a mass of crystallization magma for the main crystallizer (10) is formed from the pre-crystallisation magma by means of crystallization by cooling and / or crystallization by evaporation; the continuous supply of a solution containing the monosaccharide and a mass of crystallization magma from the at least one pre-crystallizer (15A, 15B, 15C) of the final stage (15) of the cascade to the main crystallizer (10) to provide the crystal suspension.
Owner:BRAUNSCHWEIGISCHE MASCHBAU AG

A novel enantioselective crystal floatation process

PendingEP4750545A1Crystallization by component evaporationFlotation
The present invention relates to a process for the separation of enantiomeric crystals by enantioselective crystal floatation and to a process in which preferential crystallization is combined with enantioselective crystal floatation.
Owner:BASF SE +1

Compositions that contain lipophilic plant material and surfactant, and related methods

PendingUS20260138051A1Vibration crystallizationLiquid solutions solvent extractionActive agentChemical compound
Described are liquid compositions that contain a desired (e.g., extracted) plant material such as cannabinoid, terpene, terpenoid, or the like, contained, e.g., dissolved, suspended, or emulsified, in the liquid, which contains surfactant; methods of preparing these types of liquid compositions; and methods of processing this type of liquid composition to collect, isolate, concentrate, or purify a desired target material contained in the liquid composition.
Owner:ZUMPANO MICHAEL V

Crystallization of cannabinoids

A method for crystallization of cannabinoids includes: providing a substantially pure cannabinoid isolate; dissolving the cannabinoid isolate in a crystallization solvent; removing solvent by evaporation until the solution reaches saturation; adding a seed crystal of said cannabinoid; maintaining a supersaturated solution throughout the recrystallization process by the continual evaporation of solvent throughout the crystallization process by incubating the solution under heat and / or vacuum and repeating this process until crystals of the desired size have been produced.
Owner:CHEMTOR LP

Method of preparing cannabinoids

The pharmaceutical industry is highly regulated to ensure the safety, efficacy, and quality of medicines and drug discolouration is one of the leading causes for drug recall. An object of the present invention is to provide an improved method of manufacturing cannabinoids for use in pharmaceuticals that is both stable and substantially pure. Such use of stable and substantially pure cannabinoids in pharmaceuticals will improve patient compliance to medication. The main steps of the method are decarboxylation, extraction, winterization and crystallisation.
Owner:JAZZ PHARM RES UK LTD